In re Jomed, Inc. et al., USBC, E.D. Calif. — lead debtor's counsel for medical device manufacturer (U.S. subsidiary of insolvent Dutch multinational conglomerate) in liquidating chapter 11 case; structured, negotiated and confirmed compromise plan that provided 85 % cash payment to unaffiliated unsecured creditors while avoiding lengthy and expensive
litigation over treatment of affiliates.
, USBC, E.D. Calif. — lead debtor's counsel for medical device manufacturer (U.S. subsidiary of insolvent Dutch multinational conglomerate) in liquidating chapter 11 case; structured, negotiated and confirmed compromise plan that provided 85 % cash payment to unaffiliated unsecured creditors while avoiding lengthy and expensive
litigation over treatment of affiliates.
Not exact matches
Evolution in medicine and
treatment and the ever changing world of costs in clinical negligence
litigation are the real areas of change
over this time.